Prostate focal therapy: targeted treatment with hopeful early results but debated long-term proof
Focal therapy uses MRI-identified prostate lesions and energy-based methods (cryotherapy, laser ablation, and high-intensity focused ultrasound) to destroy cancer tissue in a single session, offering quicker recovery and fewer early side effects than surgery or radiation. While some centers report high satisfaction and favorable short- to mid-term outcomes, rigorous randomized trials are lacking and major guidelines label the approach experimental; uptake remains low and coverage by insurance is inconsistent, underscoring ongoing debates about long-term cancer control versus quality of life.
